Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
Filippo SanfilippoJoshua B KnightSabino ScollettaCristina SantonocitoFederico PastoreFerdinando L LoriniLuigi TritapepeAndrea MorelliAntonio ArcadipanePublished in: Critical care (London, England) (2017)
Levosimendan reduces mortality in patients with preoperative severely reduced LVEF but does not affect overall mortality. Levosimendan reduces the need for RRT after high-risk cardiac surgery.
Keyphrases
- cardiac surgery
- left ventricular
- acute kidney injury
- cardiovascular events
- heart failure
- hypertrophic cardiomyopathy
- acute myocardial infarction
- risk factors
- mitral valve
- aortic stenosis
- blood pressure
- cardiac resynchronization therapy
- left atrial
- patients undergoing
- case report
- cardiovascular disease
- type diabetes
- acute coronary syndrome
- aortic valve
- catheter ablation